ASPEN PHARMACARE (LDZA.SG)
ASPEN PHARMACARE (LDZA.SG) operates in Diversified Metals & Mining.
ASPEN PHARMACARE (LDZA.SG) (LDZA) - Total Liabilities
Latest total liabilities as of June 2024: €54.29 Billion EUR
Based on the latest financial reports, ASPEN PHARMACARE (LDZA.SG) (LDZA) has total liabilities worth €54.29 Billion EUR as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ASPEN PHARMACARE (LDZA.SG) - Total Liabilities Trend (2016–2024)
This chart illustrates how ASPEN PHARMACARE (LDZA.SG)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ASPEN PHARMACARE (LDZA.SG) Competitors by Total Liabilities
The table below lists competitors of ASPEN PHARMACARE (LDZA.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RICOH (RIC1.SG)
STU:RIC1
|
Germany | €1.22 Trillion |
|
TAKARA HOLDINGS - Dusseldorf Stock Exchang
DU:TAX
|
Germany | €189.16 Billion |
|
A S CREATION TAP N
BE:ACWN
|
Germany | €41.34 Million |
|
OLYMPUS - Dusseldorf Stock Exchang
DU:OLY1
|
Germany | €663.55 Billion |
|
MEDecision Inc
PINK:MEDE
|
USA | $116.50K |
|
Digital Locations Inc
PINK:DLOC
|
USA | $6.82 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down ASPEN PHARMACARE (LDZA.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ASPEN PHARMACARE (LDZA.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ASPEN PHARMACARE (LDZA.SG) (2016–2024)
The table below shows the annual total liabilities of ASPEN PHARMACARE (LDZA.SG) from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | €54.29 Billion | +13.00% |
| 2023-06-30 | €48.05 Billion | +18.83% |
| 2022-06-30 | €40.43 Billion | -8.23% |
| 2021-06-30 | €44.06 Billion | -31.11% |
| 2020-06-30 | €63.95 Billion | -6.10% |
| 2019-06-30 | €68.10 Billion | -17.69% |
| 2018-06-30 | €82.74 Billion | +13.03% |
| 2017-06-30 | €73.20 Billion | +18.45% |
| 2016-06-30 | €61.80 Billion | -- |